← back to search

Zhenyu Li

University of Science and Technology of China · CN
Area of research
Oncology · Hematology
Research interest
Research interests include CAR-T cell therapy research, Multiple Myeloma Research and Treatments, Virus-based gene therapy research, and Platelet Disorders and Treatments.
h-index
27
citations
3,223
works
148
NIH funding
primary concept
Medicine
email

Recent publications

Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
The Lancet Haematology 2025cited by 17position: middledoi
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial
Nature Communications 2024cited by 96position: middledoi
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
The Lancet Haematology 2024cited by 48position: lastdoi
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐<scp>BCMA CAR</scp> T‐cell‐based therapy
American Journal of Hematology 2024cited by 18position: middledoi
Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)
Blood 2023cited by 9position: middledoi
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy
Clinical and Experimental Medicine 2023cited by 6position: middledoi
Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment
Frontiers in Immunology 2021cited by 82position: middledoi
Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells
Transplantation and Cellular Therapy 2021cited by 12position: lastdoi
The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
EMBO Molecular Medicine 2020cited by 410position: middledoi
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant
Leukemia 2020cited by 81position: middledoi
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
The Lancet Haematology 2019cited by 314position: middledoi
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies
Biology of Blood and Marrow Transplantation 2019cited by 96position: middledoi
The role of interleukin‐4 in rheumatic diseases
Clinical and Experimental Pharmacology and Physiology 2018cited by 53position: middledoi
Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium
Cardiovascular Research 2018cited by 37position: middledoi
Transcriptome Analysis of Chlorantraniliprole Resistance Development in the Diamondback Moth Plutella xylostella
PLoS ONE 2013cited by 120position: middledoi

Grants

On-chip optical biosensing methods for quantitative measurement of antibiotic resistance
NSF1743662$100,0002018–2020PIRePORTER
I-Corps: A Cloud-based Wearable ECG Sensor on a Finger Ring
NSF1837892$50,0002018–2019PIRePORTER

Frequent collaborators

Wei Sang · Shanxi Medical University8 papers (2019–2024)Kailin Xu · Vanderbilt University Medical Center8 papers (2019–2024)Ming Shi · Sun Yat-sen University Cancer Center7 papers (2019–2024)Jiang Cao · Xuzhou Medical College7 papers (2019–2024)Junnian Zheng · Auburn University6 papers (2019–2024)Zhiling Yan · University of Alberta6 papers (2019–2024)Depeng Li · Xuzhou Medical College6 papers (2019–2024)Kunming Qi · Xuzhou Medical College5 papers (2019–2024)Hujun Li · Xuzhou Medical College4 papers (2021–2024)Feng Zhu · Hebei Medical University4 papers (2021–2024)Qingyun Wu · National University of Singapore4 papers (2019–2023)Jianlin Qiao · Cell Technology (China)4 papers (2019–2023)Xiaoming Fei · Jiangsu University4 papers (2019–2024)Weiying Gu · Soochow University4 papers (2023–2024)Hongming Huang · Nanchang University3 papers (2021–2024)Huan-Xin Zhang · Nanjing Agricultural University3 papers (2019–2024)Feng Zhu · Suzhou Kowloon Hospital3 papers (2019–2021)Wei Chen · University of Liverpool3 papers (2019–2024)Haiying Sun · Union Hospital2 papers (2021–2021)Jiaojiao Wang · Sun Yat-sen University2 papers (2023–2024)